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Services for adults with cystic fibrosis1
Executive summary
Cystic fibrosis (CF) is the most common life-threat-
ening single gene inherited disorder in people of Euro-
pean descent worldwide. Increasingly, cases are
identified in other Caucasians in the Middle East and on
the Indian subcontinent. Until recently, CF has been
regarded as a children’s disease because few patients sur-
vived into adult life. However, better prevention and
management of its complications, particularly chronic
lung disease, has led to longer survival. Thus, in some
industrialised countries, there are as many affected adults
as CF children; and the proportion of CF children sur-
viving to become adults is rapidly increasing throughout
the world. Provision of services for CF adults has not
kept pace with this improved prognosis. Many adult pul-
monologists have neither the necessary training to man-
age this complex disease, nor, individually, do they have
enough patients to encourage them to develop a special
interest in CF and ensure provision of the range of serv-
ices patients need. Some CF-related conditions are spe-
cific to affected adults (e.g. fertility problems) while
others (e.g. diabetes) may affect children but become
more frequent and severe as the disease progresses.
WHO, the International CF (Mucoviscidosis) Associa-
tion ICF(M)A and the (patients’) International Adult CF
Association (IACFA) therefore convened a joint meeting
(The Hague, 7–8 June 1999) to produce recommenda-
tions for the provision of adult medical and associated
services for CF adults. The group did not consider or
make detailed clinical recommendations; because these
recommendations would soon become dated and can be
found in specialist textbooks and journals. Instead, its
scope was limited to service provision. This report pro-
vides a reference for health care providers by outlining
the range and types of specialist services required by CF
adults, in the hope that the momentum of the improving
prognosis can be maintained or accelerated. It includes
a checklist of adult medical, psychological and social
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problems associated with CF, the composition of the spe-
cialist team, physical accommodation and facilities, rec-
ommended arrangements for transitional, community
and terminal care, training of CF specialists and funding
arrangements. It reflects the experience of the profes-
sionals and patients who comprised the working party.
1. Background
Previous joint meetings between World Health Organ-
ization (WHO) Human Genetics Programme and the
International Cystic Fibrosis (Mucoviscidosis) Associa-
tion (ICF(M)A) have addressed the need for education
concerning diagnosis and management of cystic fibrosis
(CF) w1–3x.
CF is a genetic disease with significant variations in
incidence, morbidity and mortality around the world.
Although most often reported in white Caucasians, since
discovery of the mutated gene in 1989 w4x it is also being
diagnosed with increasing frequency in other popula-
tions, often with variant clinical expression. Better
understanding and treatment of CF has led to an
improved survival in countries where CF services are
well developed w5–8x. Published data from these coun-
tries report a similar mean life expectancy of greater than
thirty years, compared with survival less than a decade
30 years ago w9x. Today many CF patients reach adult
life with the consequent need for specialist care different
from pediatrics. For example in the United Kingdom it
was calculated that at the turn of the century there would
be as many adults as children with CF w4x.
The major cause of morbidity and mortality is chronic
respiratory disease, but CF is a complicated disease
affecting multiple organs which therefore requires the
involvement of a variety of medical and other specialists.
Optimal care for CF consequently needs a team approach
which can only be coordinated in specialist centres. Such
centres have developed in many countries and the ben-
efits of centre care have been clearly demonstrated w8x,
although differences in survival between individual cen-
tres have also been observed w10x. Because CF has his-
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torically been regarded as a children’s disease, CF
centres have grown up in the context of pediatric hos-
pitals which in many instances have continued to pro-
vide care into adult life. However, many countries have
strict regulations or customs for transfer of patients to
adult medicine at a defined age, which has highlighted
the need for adult CF services. Health care providers and
the medical profession have not always kept pace with
the demographic changes in the disease, and may benefit
from guidance on the development of adult CF services.
WHO Human Genetics Programme, ICF(M)A and
IACFA have convened this joint meeting to make rec-
ommendations for services for adults with CF around the
world.
2. Size of problem
With continually improving survival reported from
industrialized countries, there are now many adults with
this disease. In Scandinavia for example, over 45% of
the patients are over 18 years of age w7x. This demo-
graphic change requires services appropriate for an adult
CF population.
The requirement for separate services for CF adults
will depend upon patient numbers, and will vary
between and within countries according to the expertise
and resources available. There is a training requirement
for adult physicians interested in this disease and willing
to devote their time and energy to providing these
services.
Because CF is a progressive disease, it follows that a
disproportionate number of adults will be at the severe
end of the clinical spectrum. Thus, adult CF services can
be anticipated to be relatively more expensive than their
pediatric counterparts.
In some countries and cities it may be appropriate to
provide pediatric and adult care at the same centre; but
it even so it is necessary to provide specific services for
adults for which there is no pediatric equivalent. It is
recommended that an adult CF clinic should be estab-
lished when numbers of adults in a centre are 50 or
above.
3. Transition
Adolescents and young adults with chronic conditions
share the same developmental, social, and emotional
needs as their healthy peers. There are multiple transi-
tions that the young healthy adult has to go through:
family home to independent living, romantic partnership
and education for a career. All these transitions help the
person to become increasingly self-sufficient.
In addition, persons with a chronic disease need to
make a transition within the health care system to gain
greater personal responsibility for their illness. Improv-
ing the sense of control in the CF child, by giving chil-
dren time alone with the specialist, should be introduced
from an early age.
Problems arise in transition because there may be lim-
ited access to adult caregivers due to lack of training and
funding. There is no model which is proven superior to
others, however the physiological and psychological
development from a child into an adult must be taken
seriously.
If a combined clinic is more appropriate to the nation-
al culture, population size or resources, access and pos-
sible transfers to other doctors in the same clinic should
be available once adulthood has been reached.
It is essential to treat each adolescent as an individual
and to retain flexibility in the age at which transfer is
arranged according to the physical and emotional devel-
opment of the patient.
It is also helpful if the adult specialist is present in
certain pediatric clinic sessions so that transfer does not
imply a total break from the familiar services.
Occasionally the diagnosis of CF is delayed until teen-
age or adult life. These patients may find it more difficult
to adjust to the diagnosis and its implications than those
diagnosed in childhood.
4. Components of adult CF service
4.1. Multidisciplinary care
The care for adult CF patients must be multidiscipli-
nary since the disease affects the whole body. It also has
major psychological and social consequences for the
individual. Older patients with CF are striving for inde-
pendence, control of their situation and major input into
health management decisions. Expectations are high
because they have become accustomed to a high stan-
dard of pediatric care with individual attention.
4.2. Adult medical problems
New medical issues might arise for the CF patient in
adult life. Most of these can also affect children, but
occur with greater frequency as they become older.
These include:
● increased frequency of respiratory exacerbations;
● emergence of new pathogens;
● haemoptysis;
● pneumothorax;
● allergic bronchpulmonary aspergillosis;
● cardiac failure;
● respiratory failure;
● malnutrition;
● distal intestinal obstruction syndrome (DIOSymeco-
nium ileus equivalent);
● gallstones;
● pancreatitis;
● malignancy of the gastrointestinal tract;
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● progressive liver disease;
● portal hypertension and oesophageal varices;
● diabetes mellitus;
● nasal polyposis and sinusitis;
● osteoporosis;
● arthropathy;
● vasculitis;
● male infertility;
● pregnancy;
● preypost lung transplantation.
4.3. Psychosocial problems
The transfer of responsibility from the parents to the
CF individual involves both psychological and social
adjustments (Section 7).
4.4. Core CF team
The following personnel are required as core members
of the CF team:
● Respiratory physician and medical team;
● Clinical Nurse Specialist and home care nurse if
appropriate (Section 5.5);
● Specialist physiotherapistyrespiratory therapist;
● Specialist dietitian;
● Social worker.
Although not part of the core CF team, other health
care providers such as general practitioners and univer-
sity, college or occupational health services may contrib-
ute to the care of individuals with CF and appropriate
liaison arrangements should be made.
4.5. Consultants
The skills of the following specialists will also be
needed:
● Expert laboratory support services: microbiology, bio-
chemistry, immunology, pathology, genetics;
● Pharmacist;
● Gastroenterologist;
● General surgeon;
● Thoracic surgeon;
● Radiologist;
● Endocrinologist;
● Otorhinolaryngologist;
● AnaesthesistyIntensive care specialist;
● Infectious disease specialist;
● Psychologist with psychiatric support;
● Obstetricianygynecologist;
● Rheumatologist;
● Transplant services team;
● Geneticist;
● Pain relief team;
● Terminal care team including chaplainyreligious advi-
sor where appropriate.
4.6. Facilities
Provision of a comprehensive CF service requires
extensive organisational arrangements. These include:
● Inpatient accommodation;
● Outpatient accommodation;
● Lung function testing with facilities to prevent cross-
infection between patients;
● Facilities for isolating patients with transmissible
organisms such as Burkholderia cepacia and methi-
cillin-resistant Staphylococci (MRSA);
● Home care services;
● Shared care arrangements at outlying hospitals where
appropriate;
● Liaison with pediatric clinic including transition
arrangements.
5. Patterns of health care delivery
5.1. Established adult CF clinics
Independent adult CF Clinics have been established
for the past 20–30 years in some countries. At these
centres, all inpatient and outpatient care is provided by
a multidisciplinary team similar to that described above.
5.2. Parents and partners
In an Adult CF Clinic, patients are encouraged to take
more responsibility for their own medical care. Parents
should normally not be completely excluded (if only
because with advancing disease the patient may revert
to a greater degree of dependence), but patients in an
adult clinic need the opportunity to be seen indepen-
dently. This facilitates frank and open discussion about
relationships, contraception, adherence to therapy, pos-
sible alcohol or substance abuse and other concerns. The
family will continue to have a major role as supporters
and advocates, and in many cases adult patients involve
life partners in their health management.
5.3. Independent adult CF clinics
Wherever there are sufficient adult patients and ade-
quate resources a specialized adult clinic would seem to
be the preferred model. An adult physician and team that
is both interested and capable of providing good quality
care is fundamental to such a model. Motivation, com-
mitment and dedication of time by the team are more
important than any other consideration. If these condi-
tions cannot be met no attempt should be made to estab-
lish an independent clinic. Appropriate professional
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training of all members of the adult multidisciplinary
team is required.
5.4. Other models
There are a variety of models of adult care ranging
from an adult physician attending the pediatric clinic
through to the provision of a full and comprehensive
service being provided by an independent adult team.
The appropriate model for each clinic will depend on
numbers of adult patients, availability of skilled adult
team members and the provision of adequate resources
(financial, infrastructure, allocated time). If there are no
adequately trained and motivated personnel to provide
an adult CF team, the pediatric CF clinic will need to
develop its services and facilities to cope with the needs
of adults. This has certain advantages, in respect of con-
tinuity of care and the expert knowledge and experience
of the pediatric CF team, but may be perceived by adult
patients as continuing a parental relationship and dimin-
ishing their autonomy.
5.5. Home care and self management
Home care consists of any type of therapy provided
in the home that attempts to prevent or reduce secondary
complications of CF.
Components of home treatment involve: intravenous
(I.V.) antibiotics, intensified physiotherapy and nutri-
tional support. In addition, psychosocial support should
be offered in the home setting.
The evolution of home care options as alternatives for
traditional hospital based care highlights increased
expertise and expectations of progress in CF treatment.
Benefits and risks must be weighed carefully before
home treatment can be advised and instituted. There are
considerable differences in uptake of home care pro-
grammes between CF-care centers which may also be
influenced by national health care provision systems
including reimbursement for home care costs. Aspects of
legal responsibility for care and care complications may
arise in those under age or in those with severe advanced
disease.
The advantage of home care is that it leads to less
interruption of regular life. Home treatment might also
reduce the risk of cross-infection between CF patients,
and it decreases the financial burden for the patient and
the community since a hospital bed is not needed. Many
consider maintenance of individual independence the
most important factor offered in home care, and patients
may be less inclined to minimize symptoms if they know
that intervention does not necessarily involve admission
to hospital. However, few data exist on true cost effect-
iveness or cost utility.
The disadvantage of home care is that medical treat-
ment is less controlled. Physiotherapy and nutritional
support may be less consistent and intensive. Further-
more, the family continues to carry the burden of CF
when the patient is sick, which may lead to increased
psychological stress.
Conditions for home care:
● adequate facilities in the home;
● adequate teaching of patient and family;
● adequate physical and psychological strength of care
givers;
● medical suitability of patient;
● regular home surveillanceyguidance from the CF
center;
● availability of community doctorynurse specialist in
case of emergency.
It must be clearly stressed that home care is not an
ideal choice for all patients and careful advice and
assessment is needed.
Terminal care of the dying patient at home will
depend on local settings. If attempted, psychological
strength of caregivers must be ensured and medical and
nursing support systems must be available.
6. The adult with CF in society
The adult CF subject desires as normal a life as
possible.
Occasional patients are not diagnosed before adult-
hood. These patients may experience a period of psy-
chological adjustment with similar responses (e.g.
emotional shock, denial, relief, anger guilt depression
etc.) to those which are more usually encountered in the
parents of a newly diagnosed child, and these reactions
need to be recognized and accommodated by caregivers.
6.1. Psychological characteristics of CF adults may
include the following
Many adults with CF are dissatisfied with their phys-
ical appearance and feel unattractive. Emotional distur-
bances are mainly presented in the form of anxiety and
depression.
Normal peer relations can be difficult and CF subjects
have often met together. Recent trends have reduced this
possibility, especially in CF centres that have instituted
segregated care for CF patients. CF camps for children
and adolescents have been withdrawn due to the risk of
cross-infection. Patients may thus become socially
isolated.
There may be a delay in achieving independence from
parents with regard to both separate living and financial
support.
Children with CF may have missed significant periods
of school, sometimes through overprotection, and higher
education may not have been contemplated. Impaired
health during adolescence and adult life makes sedentary
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occupations more appropriate than manual work, but
patients often have difficulty in obtaining suitable train-
ing. Attendance at universities and colleges away from
home may involve transfer to a new and unfamiliar clin-
ic, and requires a degree of emotional independence
which some may not have achieved.
Adults with CF may have difficulty finding a partner
and are often reluctant to reveal their illness to others.
There is therefore a significantly smaller proportion of
CF adults married or cohabiting than in the normal
healthy population.
Adults with CF may become biological parents with
the help of modern reproductive technology. This raises
new ethical, emotional and medical issues for both
patients and caregivers. Before considering pregnancy, it
is essential that the subject is discussed in depth with
the couple in the best interest of themselves and the
potential child.
CF adults are less likely to be in paid employment,
the reason appearing to be predominantly health related.
Daily activities, such as looking after the home or pur-
suing a hobby may also be impaired due to ill health.
Psychosocial support is needed to help CF adults to
face the challenges of all these problems, and is an indis-
pensable component of the service provision. However,
it must be stressed that the majority of CF adults are
psychologically stable and well-adjusted, even in the
presence of advanced disease.
All team members, but most importantly the physi-
cians, must be trained to understand these worries and
struggles, so that they may help and encourage the
patients and families to attend to them and not to be
embarrassed by the team’s awareness of their existence.
Dealing with end of life issues still remains an
extremely important psychosocial issue for patients,
family members, and team members alike. It must be
recognized that giving care to chronic sick and termi-
nally ill patients is psychologically demanding, and an
important function of the CF psychologist is to counsel
and support other members of the team.
7. Training of adult CF physicians
Training will depend on the specialty from which the
trainee is coming, and will depend on the individual’s
previous level of involvement with CF adults. Although
trainees may recruited from respiratory medicine, gen-
eral internal medicine, infectious disease, gastroenterol-
ogy and immunology, the majority will be trainee
pulmonologists.
The basic training of pulmonologists differs between
countries. Consequently this leads to a difference in
knowledge of internal medicine. Therefore programmes
to train pulmonologists in CF specialised care need to
be tailored with respect to the educational background
of pulmonologists in each country. With increasing age,
other CF-related non-pulmonary complications like exo-
crine pancreatic insufficiency, diabetes, hepatobiliary
disease, distal intestinal obstruction and musculo-skeletal
disorders will contribute significantly to morbidity and
require specialised care.
Although there are no definite models for physicians
wishing to train to be centre directors in CF units, rela-
tively informal arrangements are available in Europe,
North America and Australia usually involving a 2-year
period spent as a trainee in an Adult CF Unit.
The following areas should be considered for training:
● general internal medicine, respiratory medicine and
gastroenterology;
● management of diabetes and nutrition;
● attachment to a pediatric CF unit for a period of time;
● trainees should have appropriate understanding of lab-
oratory support services;
● involved in the CF care, particularly in medical genet-
ics and microbiology;
● understanding the role of clinical psychology;
● a period of at least 2 months should be spent in a
transplantation centre; and
● performing or coordinating a research project.
For other core CF team members a period of attach-
ment to an established CF center elsewhere is highly
desirable before taking up their appointment.
8. Economics
Adult services will be relatively more expensive but
funding cannot be withdrawn from pediatric clinics if
present good survival into adult life is to be maintained.
Hospitals offering centre care for CF are confronted with
the financial burden of treating these patients. This finan-
cial burden is mostly caused by in patient expenditure.
In-hospital cost is predominantly caused by I.V. antibi-
otic treatment for exacerbations of Pseudomonas aeru-
ginosa lung infections. Additionally with increasing age,
resistance becomes more prominent requiring newer and
more expensive antibiotics.
Including the CF services in the general hospital med-
ical budget leads to complaints and antagonism among
staff when it is realised that the CF services consume a
disproportionate amount of money. It is therefore strong-
ly advised that the funding for CF services should be
separately identified and provided.
Because days in hospital account for most of the CF
expenditure the most effective way to reduce costs is to
keep patients out of the hospital.
Home I.V. therapy with antibiotics for treatment of
infectious exacerbations is the best example. Multiple
studies have shown that home I.V. antibiotic treatment
is a viable option for selected patients who are evaluated,
trained and monitored by a CF team experienced in
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home care. It may lead to a reduction in costs and is less
disruptive to the patients and their families.
New therapies may decrease the number of hospital-
isations but they tend to be very expensive when first
introduced. It is therefore important that they are prop-
erly evaluated before gaining general acceptance and
such studies can only be undertaken by collaboration
between CF units. Although they may eventually reduce
the long-term cost of treatment they inevitably increase
costs in the short to medium term. Cost effectiveness
should be part of the evaluation of new therapies. Useful
patient outcomes when undertaking economic evaluation
of CF care should include pulmonary function, nutrition,
quality of life and long-term survival.
It is recognised that not all patients have equally
severe disease and consideration can be given to costing
patient care according to grades of patient disease sever-
ity w11x.
9. Recommendations
1. The medical profession and health care providers
should be educated about the requirement for adult
CF services in their country.
2. The distinctive medical, emotional, social and eco-
nomic needs of adolescent and adult CF patients
should be recognised.
3. Adult CF services are best provided in special, ade-
quately staffed and funded adult-oriented clinics.
4. Where independent adult CF clinics cannot be jus-
tified because of insufficient numbers of patients,
appropriate services and facilities for CF adults
should be provided within the framework of an all-
age service led by the pediatric CF clinic director.
5. Adult CF clinics should be located in large medical
centres where the expertise of a multidisciplinary
team of consultants is available.
6. Physicians, nurses, physiotherapists, dieticians and
social workers providing CF care for adults should
be given adequate training at established CF centres.
Training programs for CF centre directors are urgent-
ly needed.
7. Adult CF patients must take the major responsibility
for compliance with their health care programs but
parents and partners should not be excluded because
they have vital supportive roles.
8. Wherever possible, for both medical and economic
reasons, care should be provided at home by CF
team personnel, for suitable patients.
9. Adult patients should have clearly defined access
and input into management policies of their clinic.
10. Adult CF clinics should have a budget clearly sep-
arated from the general budget of the hospital.
11. In the expectation that future drugs designed to pro-
mote a cure for CF will be expensive, the cost and
benefit of new treatments should be rigorously
evaluated.
12. WHO, ICF(M)A and IACFA should keep the pro-
vision of adult CF services under review and make
further recommendations if indicated.
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